Fed. Circ. Won't Rehear OxyContin Patent Claims
The Federal Circuit on Monday turned down an appeal by prescription opioid maker Purdue Pharma LP to rethink its decision upholding a Patent Trial and Appeal Board order that invalidated claims...To view the full article, register now.
Already a subscriber? Click here to view full article